Apomorphine, central dopaminergic pathways and control of penile erection;Apomorphine, systèmes dopaminergiques centraux et contrôle de l'érection

Andrologie

Volumn 12, Issue 2, 2002, Pages 156-166

  Rampin, Olivier ^a  

^a CEMAGREF   (France)

Author keywords

Apomorphine; Dopamine; Ejaculation; Erectile dysfunction; Erection; Sexual behavior

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4,7 DIMETHOXY N,N DIPROPYL 2 INDANAMINE; ALNESPIRONE; APOMORPHINE; B HT920; BACLOFEN; BROMOCRIPTINE; BUSPIRONE; CQP 201403; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; HALOPERIDOL; LISURIDE; METOCLOPRAMIDE; MORPHINE; MUSCIMOL; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; NEUROTENSIN; PINDOLOL; PRAMIPEXOLE; PRECLAMOL; QUINELORANE; QUINPIROLE; SULPIRIDE; TALIPEXOLE;

ADRENERGIC SYSTEM; ARTERY BLOOD FLOW; BRAIN STEM; CHOLINERGIC SYSTEM; CLINICAL TRIAL; DOPAMINERGIC NERVE CELL; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EJACULATION; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; HUMAN; HYPOTHALAMUS; MALE; METABOLITE; NERVE ENDING; NONHUMAN; PENIS ARTERY; PENIS ERECTION; PERIPHERAL NERVE; PONS; REVIEW; SACRAL SPINAL CORD; SEXUAL BEHAVIOR;

EID: 0036619288     PISSN: 11662654     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03034962     Document Type: Review

References (140)

1. Pharmacology of penile erection
2. The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat
3. Physiology of penile erection
4. Suppression by prolactin of the electrically induced erectile response through its direct effect on the corpus cavernosum penis in the dog
5. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats
6. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats
7. Treatment of fluoxetine-induced anorgasmia with amantadine
8. Apocodeine-induced stereotypies and penile erection in rats
9. Dose dependent D2 effects on genital reflexes after MPOA injections of quinelorane and apomorphine
10. Dopamine as a prolactin (PRL) inhibitor
11. Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats
12. Activation with N-npropyl-norapomorphine (NPA) of the male rat copulatory behavior
13. Opiate-androgen interactions in drug-induced yawning and penile erections in the rat
14. Intracavernous pressure during erection in rats: An integrative approach based on telemetric recording
15. Pharmacological analysis of male sexual behavior
16. Quinelorane (LY 163502), a D2 dopamine receptor agonist, facilitates seminal emission, but inhibits penile erection in the rat
17. Painful clitoral tumescence during bromocriptine therapy
18. Sexual behavior during L-DOPA treatment for Parkinsonism
19. Sexual function and affect in Parkinsonian men treated with L-DOPA
20. Hyperprolactinemia and sexual function in men
21. Dopaminergic neurotransmission at the paraventricular nucleus of the hypothalamus in central regulation of penile erection in the rat
22. Role of subcutaneous apomorphine in parkinsonian voiding dysfunction
23. Effects of a novel dopamine-receptor agonist, RDS-127 (2-N,N-di-n-propylamino-4,7-dimethoxyindane), on hormone levels and sexual behavior in the male rat
24. Further studies on alterations in male rat copulatory behavior induced by the dopamine-receptor agonist RDS-127
25. Central effects of RDS-127: Sexual behavior after intracerebroventricular administration and in vitro receptor binding studies
26. Bromocriptine in impotence
27. Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease
28. Assessment of erectogenic drugs by numeric plethysmography
29. Assessment of erectogenic properties of apomorphine and yohimbine in man
30. Treatment rapidly improves gonadal function in hyperprolactinemic males: A comparison with bromocriptine
31. Effects of chronic hyperprolactinemia on sexual arousal and erectile function in male rats
32. Hyperprolactinemia preferentially inhibits erectile function in adrenalectomized male rats
33. Stimulatory effects of quinelorane on yawning and penile erection in the rat
34. Short-term endogenous hyperprolactinemia and sexual behavior of male rats
35. Castration decreases extracellular, but increases intracellular, dopamine in medial preoptic area of male rats
36. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction
37. D2 receptors in the paraventricular nucleus regulate genital responses and copulation in male rats
38. Apomorphine versus mating behavior in testing erectile capabilities of diabetic rats
39. Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates
40. Potentiation of the aphrodisiac effect of N-n-propyl-norapomorphine by naloxone
41. Sexual excitement and stretching and yawning induced by B-HT 920
42. Behavioural effects induced in rats and chicks by D2 dopamine agonists
43. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist
44. The selective D2 dopamine receptor antagonist eticlopride counteracts the ejaculatio praecox induced by the selective D2 dopamine agonist SND 919 in the rat
45. Amantadine stimulates sexual behavior in male rats
46. How REM sleep deprivation and amantadine affect male rat sexual behavior
47. Changes in monoamine turnover in forebrain areas associated with masculine sexual behavior: A microdialysis study
48. Dopamine and temperature regulation in the primate: Effects of apomorphine and pimozide
49. Effects of depression and antidepressants on sexual functioning
50. Differential behavioral response to dopamine D2 agonists by sexually naïve, sexually active, and sexually inactive male rats
51. Animal models used in the study of erectile dysfunction
52. Spinal proerectile effect of apomorphine in the anesthetized rat
53. Pro-erectile effect of systemic apomorphine: Existence of a spinal site of action
54. Dopamine and male sexual function
55. Vasomax for the treatment of male erectile dysfunction
56. Oral sildenafil in the treatment of erectile dysfunction
57. The characterization of a bio-assay of erectile function in a rat model
58. Metoclopramide decreases apomorphine-induced yawning and penile erection
59. Effects of castration and exogenous testosterone supplementation in an animal model of penile erection
60. Recovery of erectile function by the oral administration of apomorphine
61. Key issues from the clinical trials of apomorphine SL
62. Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction
63. Association of spontaneous and dopaminergic-induced yawning and penile erections in the rat
64. T. Effects of levodopa on nocturnal penile tumescence: A preliminary study
65. Dopaminergic control of male sex behavior in rats: Effects of an intracerebrally-infused agonist
66. Dopamine receptors in the ventral tegmental area modulate male sexual behavior in rats
67. Opposite influence of medial preoptic D1 and D2 receptors on genital reflexes. Implication for copulation
68. Extracellular dopamine in the medial preoptic area: Implications for sexual motivation and hormonal control of copulation
69. Hormone-neurotransmitter interactions in the control of sexual behavior
70. The activating effect of L-DOPA treatment on sexual functions and its experimental background
71. Effects of spinal alpha-1 adrenoceptor antagonism on bladder activity induced by apomorphine in conscious rats with and without bladder outlet obstruction
72. Stimulation of bladder activity by volume, L-DOPA and capsaicin in normal conscious ratseffects of spinal alpha-1 adrenoceptor blockade
73. Apomorphine induces ejaculation in chronic decerebrate rats
74. Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence: A case report
75. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects
76. Apomorphine-induced penile tumescence in impotent patients-preliminary findings
77. Apomorphine: Clinical studies on erectile impotence and yawning
78. Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: An open study
79. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants
80. Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats
81. Effects of LSD-25, clonidine and apomorphine on copulatory behavior in the male rat
82. Monoamine precursors and copulatory behavior in the male rat
83. Brain somatostatin depletion by cysteamine attenuates the penile erection induced by serotonergic and dopaminergic, but not by cholinergic, activation
84. Dopamine release in the medial preoptic area of female rats in response to hormonal manipulation and sexual activity
85. Neural circuitry involved in sexual function
86. The physiology of male sexual behavior
87. Apomorphine-induced penile erection and yawning: Site of action in the brain
88. Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system
89. Hippocampal oxytocin mediates apomorphine-induced penile erection and yawning
90. Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats
91. Prevention by Ng-nitro-L-arginine methyl ester of apomorphine-and oxytocin-induced penile erection and yawning: Site of action in the brain
92. Apomorphine- and oxytocin-induced penile erection and yawning in intact and castrated male rats: Effect of sexual steroids
93. Dopamine and sexual behavior
94. Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: Correlation with penile erection and yawning
95. Prevention by morphine of apomorphine- and oxytocin-induced penile erection and yawning: Involvement of nitric oxide
96. Dopamine receptors: From structure to function
97. Effects of castration, steroid replacement, and sexual experience on mesolimbic dopamine and sexual behaviors in the male rat
98. Sublingual apomorphine for the treatment of erectile dysfunction
99. Electrophysiologic and hemodynamic effects of apomorphine in dogs
100. Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats
101. Inhibition of apomorphine-induced yawning and penile erection by neurotensin
102. Apomorphine-induced penile erections in Parkinson's disease
103. Apomorphine and L-DOPA lower ejaculation threshold in the male rat
104. Apomorphine and haloperidol, but not domperidone, affect penile reflexes in rats
105. The effects of intracranial administration of the dopamine agonist apomorphine on penile reflexes and seminal emission in the rat
106. Cholecystokinin facilitates ejaculation in male rats: Blockade with proglumide and apomorphine
107. Sexual behavior enhances central dopamine transmission in the male rat
108. Male diabetic impotence: Effects of dopaminergic agents
109. Correlation of dopamine release in the nucleus accumbens with masculine sexual behavior in rats
110. Apomorphine facilitates male sexual behavior of rhesus monkeys
111. Quinelorane (LY 163502), a D2 dopamine receptor agonist, acts centrally to facilitate penile erections of male rhesus monkeys
112. Testosterone restoration of copulatory behavior correlates with medial preoptic dopamine release in castrated male rats
113. Experimental hyperprolactinemia in a rat model: Alteration in centrally mediated neuroerectile mechanisms
114. Contextual approaches to the physiology and classification of erectile function, erectile dysfunction, and sexual arousal
115. Suppressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apomorphine to pituitary-transplanted rats
116. Systemic or intracranial apomorphine increases copulation in long-term castrated male rats
117. Treatment of alcoholism with Dent's oral apomorphine method
118. Apomorphine in Parkinson's disease
119. Effect of apomorphine on penile tumescence in men with psychogenic impotence
120. Cycloheximide prevents apomorphine-induced yawning, penile erection and genital grooming in rats
121. Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine
122. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists
123. Disorders of the basal ganglia
124. Effects of a potent dopamine receptor agonist, RDS-127, on penile reflexes and seminal emission in intact and spinally transected rats
125. Dopamine-stimulated sexual behavior is testosterone dependent in mice
126. Evidence that brain dopamine stimulates copulatory behavior in male rats
127. Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats
128. Possible stimulatory role of brain dopamine in the copulatory behavior of male rats
129. Systemic administration of apomorphine improves the hemodynamic mechanism of clitoral and vaginal engorgement in the rabbit
130. Hypersexuality with antiparkinsonian therapy
131. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients
132. The management of erectile dysfunction in the community
133. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction
134. Dopamine activates masculine sexual behavior independent of the estrogen receptor alpha
135. Synthetic melanotropic peptide initiates erection in men with psychogenic erectile dysfunction: Double-blind, placebo controlled crossover study
136. Effects of apomorphine, physostigmine and vasoactive intestinal polypeptide on penile erection and yawning in diabetic rats
137. The action of L-DOPA on schizophrenic patients; a preliminary report
138. Evaluation of apomorphine HCI effects on reproductive endpoints: Studies in male rats and dogs
139. Opposite influence of dopaminergic receptor subtypes on penile erection
140. Effects of GABAergic drugs on penile erection induced by apomorphine in rats